Nasdaq Reports October 2025 Volumes
Globenewswire· 2025-11-04 21:05
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for October 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. W ...
Amwell® Announces Results for Third Quarter 2025
Globenewswire· 2025-11-04 21:05
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third quarter ended September 30. The company’s third quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. ...
Postal Realty Trust, Inc. Reports Third Quarter 2025 Results
Globenewswire· 2025-11-04 21:05
- Increased 2025 AFFO Guidance $0.06 to $1.30 - $1.32 Per Diluted Share -- Amended, Extended, and Expanded Unsecured Credit Facilities to $440 Million -- U.S. Postal Service Operations Not Affected by Government Shutdown -- Acquired 47 USPS Properties for $42.3 million at a Weighted Average Capitalization Rate of 7.7% -- Raised $26.0 Million from ATM Program During Q3 to Fund Acquisitions - CEDARHURST, New York, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an int ...
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
Globenewswire· 2025-11-04 21:05
NEWTOWN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (“Solana” or the “Company”) today announced that it has applied to the British Columbia Securities Commission, as principal regulator, and the Ontario Securities Commission, for an order under the securities legislation of British Columbia and Ontario (the “Requested Order”) that the Company has ceased to be a reporting issuer in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Québec, New Brunswick, Nova Scotia, Prince ...
DMC Global Reports Third Quarter Financial Results
Globenewswire· 2025-11-04 21:05
Third quarter sales were $151.5 millionNet loss attributable to DMC was $3.1 millionAdjusted net loss attributable to DMC* was $1.6 million, or $(0.08) per diluted shareAdjusted EBITDA attributable to DMC* was $8.6 million, while total adjusted EBITDA, inclusive of non-controlling interest (NCI), was $12.0 millionNet debt* reduced to $30.1 millionRecord order at NobelClad drives backlog recovery BROOMFIELD, Colo., Nov. 04, 2025 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today reported financial resu ...
Standard BioTools Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-04 21:05
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended September 30, 2025. Recent Highlights: Third quarter 2025 total combined company revenue of $46.2 million; Revenue from continuing operations of $19.6 millionImplemented restructuring plan expected to deliver over $40 million in annualized cost savings; On track to achieve positive adjusted EBITDA target in 2026$217 ...
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2026
Globenewswire· 2025-11-04 21:05
SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2025. First Quarter Fiscal 2026 Summary*: Revenue was $47.6 million, an increase of 0.7% from the prior year period. Excluding the impact of foreign currency fluctuations, first quarter revenue increased approximately 0 ...
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
Globenewswire· 2025-11-04 21:05
Final Data from VAX-24 Infant Phase 2 Dose-Finding Study Consistent with Previously Reported Positive Interim Data; Provide Additional Evidence Supporting Higher VAX-31 Doses Being Evaluated in Ongoing Infant Phase 2 Study Modified VAX-31 Infant Phase 2 Dose-Finding Study Advanced to Third and Final Stage Company Expects to Initiate VAX-31 Adult Pivotal, Non-Inferiority Study in December 2025 with Topline Data in 2026 Company Establishing Fill-Finish Manufacturing in North Carolina as Key Element of Long-T ...
Workhorse Group Recommends Shareholders Follow Recommendations of Leading Independent Proxy Advisory Firms to Vote FOR Motiv Transaction Today
Globenewswire· 2025-11-04 21:05
ISS and Glass Lewis Both Recognize Compelling Value Transaction Delivers to Workhorse Shareholders Visit votewkhs.com for Information on How to Vote CINCINNATI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) ...
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
Globenewswire· 2025-11-04 21:05
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that it will report its third quarter 2025 financial results and provide a business update on Thursday, November 13, after the market close. The Company does not intend to host a conference call. About Spero TherapeuticsSpero Therape ...